✦ LIBER ✦

Withdrawal of immunosuppression in liver allograft recipients

✍ Scribed by Padbury, Robert T.A. ;Toogood, Giles J. ;McMaster, Paul

Publisher: Wiley (John Wiley & Sons)
Year: 1998
Tongue: English
Weight: 85 KB
Volume: 4
Category: Article
ISSN: 1074-3022
DOI: 10.1002/lt.500040309

No coin nor oath required. For personal study only.

✦ Synopsis

S trategies to minimize the long-term side effects of immunosuppression in liver transplant recipients have included the uniform reduction of all agents in double-or triple-therapy regimens, selective discontinuation of individual agents of such regimens, and the complete withdrawal of all long-term immunosuppression. The most effective clinical protocol to eliminate the serious cardiovascular, infectious, and neoplastic complications while preventing immunologic graft damage is not yet apparent.

📜 SIMILAR VOLUMES

Present state of immunosuppressive thera

Present state of immunosuppressive therapy in liver transplant recipients

✍ Russell H. Wiesner; John J. Fung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

## Key Points 1. Our increasing understanding of the signaling pathways and cellular interactions in transplant immunobiology has facilitated targeted strategies using novel immunosuppressive agents. 2. The pattern of immunosuppressive drug use in the United States continues to change, and the chan

Defining the outcome of immunosuppressio

Defining the outcome of immunosuppression withdrawal after liver transplantation

✍ John Devlin; Derek Doherty; Linda Thomson; Terence Wong; Peter Donaldson; Bernar 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Successful immunosuppression withdrawal should benefit the natural history of organ transplantation patients. To identify the clinical hazards of removing drug treatment and possible characteristics that predict a favorable outcome in long-term liver recipients, immunosuppression was withdrawn compl

Is immunosuppression therapy in renal al

Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience

✍ Bar, Jacob ;Stahl, Bracha ;Hod, Moshe ;Wittenberg, Clara ;Pardo, Joseph ;Merlob, 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Immunosuppression in HCV-positive liver

Immunosuppression in HCV-positive liver transplant recipients: Pandora's box?

✍ Olivier Boillot; Jérôme Dumortier 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

Allograft rejection in pediatric recipie

Allograft rejection in pediatric recipients of living related liver transplants

✍ E M Alonso; J B Piper; G Echols; J R Thistlethwaite; P F Whitington 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

The purpose of this study was to compare the inci-dence and severity of rejection episodes in a group of dence and severity of rejection episodes in a group of children receiving living related orthotopic liver transchildren receiving living related orthotopic liver transplants (LRLT) versus patient

Incidence of severe ventricular arrhythm

Incidence of severe ventricular arrhythmias during pulmonary artery catheterization in liver allograft recipients

✍ Mi Sook Gwak; Jie Ae Kim; Gaab Soo Kim; Soo Joo Choi; Hyun Ahn; Jeong Jin Lee; S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Liver allograft recipients may develop a hyperdynamic circulation and cardiac electrophysiologic abnormalities. The incidence of severe ventricular arrhythmias in liver allograft recipients during pulmonary artery (PA) catheterization was determined. One hundred five liver allograft recipients were